Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
Shipping traffic through the Strait of Hormuz remains minimal even after the US and Iran agreed to a ceasefire

Shipping traffic through the Strait of Hormuz remains minimal even after the US and Iran agreed to a ceasefire

101 finance101 finance2026/04/10 03:18
By:101 finance

Strait of Hormuz Shipping Stays Disrupted Despite US-Iran Ceasefire

Maritime activity in the Strait of Hormuz continues to be severely limited, even after the United States and Iran agreed to a temporary ceasefire. Hopes for a swift end to one of the most significant global energy supply interruptions remain low. Ship tracking reports reveal that since the announcement of a two-week halt in hostilities on Tuesday, only a small number of vessels have managed to pass through this vital waterway.

Data from the market intelligence provider Kpler shows that just five ships made the crossing on Wednesday, a sharp decrease from the eleven recorded the previous day. On Thursday, seven vessels were able to transit the strait. Meanwhile, over 600 ships—including 325 oil tankers—are still waiting, unable to proceed through the congested passage.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

New Non-Opioid Pain Relief Company Latigo (LTGO.US) Plans IPO to Raise Up to $288 Million, Nav1.8 Inhibitor Targets Vertex Pharmaceuticals (VRTX.US) Billion-Dollar Market

Pain therapy biotechnology company Latigo Biotherapeutics has finalized the terms for a $272 million IPO.

智通财经2026/08/04 09:16
New Non-Opioid Pain Relief Company Latigo (LTGO.US) Plans IPO to Raise Up to $288 Million, Nav1.8 Inhibitor Targets Vertex Pharmaceuticals (VRTX.US) Billion-Dollar Market

Earnings Preview | Pfizer (PFE.US) and Merck (MRK.US) Announce Results on the Same Day: As Patent Cliff Meets New Growth Engines, the Pharmaceutical Industry Faces a Valuation Test

Pfizer and Merck released their Q2 earnings report on the same day: one faces the major test of the “post-COVID era,” while the other is making a final push before the impending patent cliff for Keytruda.

智通财经2026/08/04 08:31
Earnings Preview | Pfizer (PFE.US) and Merck (MRK.US) Announce Results on the Same Day: As Patent Cliff Meets New Growth Engines, the Pharmaceutical Industry Faces a Valuation Test